MyPsoriasisTeam

It sounds like you're asking about Sotyktu (deucravacitinib) and why it might not have come up in a previous conversation.

Sotyktu is an FDA-approved oral medication for adults with moderate to severe plaque psoriasis. It's taken once daily and works by blocking the TYK2 protein, which helps calm the immune signals that Show Full Answer

It sounds like you're asking about Sotyktu (deucravacitinib) and why it might not have come up in a previous conversation.

Sotyktu is an FDA-approved oral medication for adults with moderate to severe plaque psoriasis. It's taken once daily and works by blocking the TYK2 protein, which helps calm the immune signals that trigger psoriasis symptoms.

In clinical trials, people taking Sotyktu showed significant improvement compared to those on placebo or other treatments like Otezla. It's considered a major advancement because it offers effectiveness similar to biologics but in pill form rather than injections.

If you'd like to know more about Sotyktu specifically—like how it works, who can take it, or what side effects to watch for—feel free to ask!

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

FDA Approves New Oral Drug Sotyktu for Adults With Plaque Psoriasis